Combined Alcohol and Drug Abuse Problems. Edward Gottheil, Section Editor
|
|
- Gwenda Garrison
- 5 years ago
- Views:
Transcription
1 Combined Alcohol and Drug Abuse Problems I Edward Gottheil, Section Editor
2 Overview Edward Gottheil Although people have been using and abusing many substances for many centuries, the field of addiction is relatively new. It probably had its origins in the 1940s when it gained public and scientific attention mainly through the efforts of Alcoholics Anonymous and the National Council on Alcoholism. There was further recognition in the 1950s, with acceptance by the American Medical Association and inclusion in the Diagnostic and Statistical Manual (DSM) of the American Psychiatric Association. It was firmly established with the creation of the National Institute on Alcohol Abuse and Alcoholism (NJAAA). Prior to the 1960s, the field was not very complicated. To be sure, there was much to be learned, but the main research and clinical problems, by far, were those relating to alcoholism. The field expanded markedly with the drug abuse epidemic of the 1960s and the establishment of the National Institute on Drug Abuse (NIDA). Currently, the field may be undergoing another expansion with the emergence of cocaine use and abuse and becoming more complicated with the steadily increasing numbers of polydrug abusers. Since the field is as young as it is and there are so many gaps in our knowledge regarding the epidemiology, etiology, pharmacology, diagnosis, and treatment of alcoholism and narcotic addiction, to say nothing of cocaine abuse and the many other substance abuse disorders, it is not surprisjng that research and clinical programs have tended to focus either on alcoholism or on drug abuse and to avoid studying and treating combined disorders. Indeed, there are still many problems regarding definition and classification and whether there should be a unified field of addiction. We thought it would be worthwhile, therefore, to bring together reviews of what was known about the epidemiology, interactive mechanisms, pharmacologic management, and psychosocial treatment of combined substance use disorders. Any attempt to study the prevalence of polydrug use must begin by specifying what is to be counted. What constitutes abuse and what qualifies as combined or multiple abuse? In the case of illicit drugs, any use may be considered abuse even though we know that some individuals are able to Edward Gottheil Department of Psychiatry and Human Behavior, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania M. Galanter et al. (eds.), Recent Developments in Alcoholism Springer Science+Business Media New York
3 4 I Combined Alcohol and Drug Abuse Problems use some of these drugs recreationally without any escalation of use and without any apparent adverse consequences. If occasional use of marijuana is not to be counted, or if DSM III criteria for abuse are to be employed, this must be explicitly stated. For licit drugs such as alcohol, tobacco, or prescribed substances, it is clear that abuse must be defined and distinguished from use. It is also necesssary to indicate whether abuse of one substance along with use, but not abuse, of other substances is to be included or excluded; i.e., do we count an alcoholic who smokes one package of cigarettes per day and occasionally uses marijuana and cocaine in social situations? Moreover, should we include multiple sequential users as well as multiple concurrent users, i.e., does an individual who sniffed glue as a child, was an amphetamine abuser during his teens, and who recently began taking heroin qualify? Once the data are collected and tabulated, the next issue is how to classify the possible combinations. There are 362,880 combinations of ten drugs taken two at a time. The possibilities increase markedly if we consider more than ten drugs which may also be taken three, four, or five at a time; and we have not yet considered the amount ingested of each drug in the combination, the frequency of use, and the route of administration. In Chapter 1 Clayton discusses such issues and critically reviews the various ways that have been used to describe patterns of multiple drug use: developmental patterns of onset, drug clusters, typologies of drug users, and the construction of composite indices intended to reflect the seriousness of drug use. Clayton then goes on to examine the information available in several national data sets to ascertain the extent of multiple drug use and comes to the straightforward conclusion that multiple drug use is pervasive. In view of this reality, he suggests we rethink some of our ideas and reexamine some of our studies that almost automatically attribute automobile accidents to alcohol and overdose deaths to heroin and that we inquire whether and to what extent specific combinations of multiple drugs may playa role in the occurrence of these adverse consequences. Similarly, he discusses policy issues relevant to prevention and treatment that may require reevaluation. For example, current concerns about health care costs are resulting in policies that focus on lengths of stay for specific treatments of specific conditions, while, at the same time, the increasing prevalence of multiple drug use is resulting in patients entering treatment who often do not come in the sizes and shapes that fit the particular slots specified by our treatment system. Multiple drugs may be used for enhancement (e.g., alcohol and valium) or counteraction (e.g., cocaine and heroin). These interactions, or at least some of them, have been learned on the "street" and are not new to the pharmacologist. However, the number of studies needing to be done to determine the effects of so many different combinations of drugs that vary in their acute and chronic patterns of use and in their dosage, frequency, and route of administration is staggering. Schoerner in Chapter 2 notes that when we take into account the dynamic and kinetic processes of the individual drugs, as well as their interactions in combinations, and also factor in the
4 I Overview 5 different time frames and drug use histories that occur in real life, we are faced with a situation of virtually infinite complexity because of the everchanging bloodlbrain levels of free drug and the functional tolerance and dependence that are engendered to varying degrees over time. He emphasizes the need for subjecting these interactions to sophisticated multivariate analyses, which at present are only in their infancy. Nevertheless, much is known about the basic principles of drug interactions. Schoerner illustrates these principles with respect to the depressant group of drugs. He reviews the pharmacodynamic and pharmacokinetic properties of ethanol, the benzodiazepines, and the sedative hypnotics and discusses the various types of mechanisms involved in their depressant actions and interactions. Cushman (Chapter 3) also comments about the increasing use of combinations of drugs and the gaps in our knowledge about interactions among them. He gives examples that emphasize the importance of recognition and diagnosis for the appropriate medical management of these conditions. The acute and chronic actions of these drugs, alone and in combination, are reviewed in relation to the development of appropriate principles of treatment. Throughout the chapter, practical issues related to clinical management are considered, such as the effects of adulterants when street drugs have been used, indications for inpatient detoxification, and the special problems for the anesthesiologist of tolerance and cross-tolerance. In the final chapter of this section, Carroll (Chapter 4) contends that to continue to maintain the current segregation of alcohol dependence and drug dependence programs in the face of mounting clinical and scientific evidence of the preeminence of multiple substance abuse makes no sense. It may lead to inadequate diagnoses, a failure to admit many cases with multiple substance abuse, incomplete treatment, a lack of understanding of the epidemiology of substance abuse, and, worst of all, relapse to addiction subsequent to treatment. He proposes the adoption of a II generic" perspective of addictions or substance abuse problems, according to which the choice of a particular substance and its particular manifestations is less important than the fact that one is abusing some substance capable of leading to dependence and addiction. Although there are differences that are important for detoxification and medical management, the etiology, defenses, dynamics, and therapeutic principles are seen as essentially similar regardless of the substance or substances abused. From this perspective, varieties of combined treatment methodologies are described in detail, as well as implications for staffing and training. It seems apparent that multiple substance abuse is a real and pervasive public, clinical, and scientific problem. As a research area it should be extremely attractive to investigators of many disciplines. It is an important problem; there is a need to know; and the area is not uncharted. Many of the principles and techniques are available and gaps in our knowledge are clearly identified. Yet, there are effective barriers to such research resulting
5 6 I Combined Alcohol and Drug Abuse Problems from the segregation of our alcohol and drug research and treatment institutions. Earlier in this century, the psychoanalysts searching for broad psychodynamic explanations of behavior were impressed by the many similarities they found in the histories of alcoholics and drug addicts. Together with smokers, gamblers, and the obese, they were seen as deriving from difficulties encountered during the oral stage of psychosexual development and considered as varieties of impulse disorders. In recent decades, however, alcoholism and drug addiction reappeared as separate entities. NIAAA was established in response to the pressure of Alcoholics Anonymous and the National Council on Alcoholism, and, later, NIDA was created almost overnight in response to the drug abuse epidemic of the 1960s. Representing different constituencies, their research and treatment programs, not surprisingly, were not integrated but underwent separate developments with little overlap. While the psychoanalysts had emphasized similarities among individuals, the programs funded by separate institutes emphasized differences between substances. Although there are notable exceptions, by and large, NIAAA funds research on alcoholism and NIDA funds research on drug abuse; the alcoholic goes to an alcoholism treatment program, and the drug abuser goes to a drug abuse treatment program. Where, then, is the researcher interested in studying combined alcohol and drug abuse problems to go for funds or subjects? The institutionalized separation of alcoholism and drug addiction has become ingrained in our thought and language patterns. It seems perfectly natural to talk about alcohol and drug abuse even though alcohol is a drug. We would not talk about cows and animals, since the class of animals includes cows. We would refer to cows and other animals. Interestingly, to our programmed ears, alcohol and other drug abuse sounds stilted though correct, and we prefer alcohol and drug abuse though incorrect. There has been some movement toward reintegration. Combined alcohol and other drug abuse research, prevention, teaching, and clinical programs have been developed and have been funded. Journals and national societies are reflecting this movement. Yet, much remains to be done and much remains to be learned about combined or multiple substance abuse. In the meantime, whether our researchers, administrators, and program planners are ready or not, our clinicians are continuing to see steadily increasing numbers of polydrug abusers.
Typologies of Alcoholics. Thomas F. Babor and Roger E. Meyer, Section Editors
Typologies of Alcoholics II Thomas F. Babor and Roger E. Meyer, Section Editors Overview Thomas F. Babor and Roger E. Meyer Readers whose curiosity is likely to be aroused by the concept of alcoholic typologies
More informationBRIEF REPORT PREVENTING ILLICIT DRUG USE IN ADOLESCENTS: LONG-TERM FOLLOW-UP DATA FROM A RANDOMIZED CONTROL TRIAL OF A SCHOOL POPULATION
Pergamon Addictive Behaviors, Vol. 25, No. 5, pp. 769 774, 2000 Copyright 2000 Elsevier Science Ltd Printed in the USA. All rights reserved 0306-4603/00/$ see front matter PII S0306-4603(99)00050-7 BRIEF
More informationNIDA Quick Screen V1.0F1
NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few
More informationBENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE. Steven P. Kurtz and Mance E. Buttram
BENZODIAZEPINE DEPENDENCE AMONG MULTIDRUG USERS IN THE CLUB SCENE Steven P. Kurtz and Mance E. Buttram Global Addiction 2016 2 4 October 2016 Venice, Italy This research was supported by grant number DA0196048
More informationTHE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours. Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved
THE ADDICTED BRAIN: WHAT S GOING ON IN THERE? 3 CE hours Sandra Morgenthal, PCC-S, CCFC, RN Copyright 2016 Sandra Morgenthal All rights Reserved You can contact this author at sandymorgenthal@yahoo.com
More informationAlberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007
Alberta Alcohol and Drug Abuse Commission POSITION ON ADDICTION AND MENTAL HEALTH POSITION The Alberta Alcohol and Drug Abuse Commission (AADAC) recognizes that among clients with addiction problems, there
More informationDrug Misuse Research Division
Drug Misuse Research Division Contents Occasional Paper p No. 12/ 9/ 2003 2004 Trends in treated problem drug use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to
More information9. In comparing the relative toxicity of marijuana and cocaine, it is important to take into account A. the user's gender. B. availability and price.
02 Student: 1. The Canadian government, in the early 1900s had virtually no laws regulating the sale and use of drugs. In general the government took a "hands-off" approach that has been referred to as
More informationHarm Reduction Approaches:
Harm Reduction Approaches: Click Working to edit With Master Complexity title style Click to edit Master subtitle style Facilitated by: Dale Kuehl Clinical Day, May 1, 2014 Centre for Addiction and Mental
More informationThe drug epidemic. u Currently it is estimated that 300 million people worldwide are either experimenting, or are addicted to drugs.
An epidemic A widespread occurrence of an infectious or other disease in a community at a particular time. The usual response of the public health authorities originally was to isolate those infected,
More informationReceipt of Services for Substance Use and Mental Health Issues among Adults: Results from the 2015 National Survey on Drug Use and Health
September 2016 Receipt of Services for Substance Use and Mental Health Issues among Adults: Results from the 2015 National Survey on rug Use and Health Authors SAMHSA: Eunice Park-Lee, Rachel N. Lipari,
More informationDrug and Alcohol Problems in the Criminal Justice System
Drug and Alcohol Problems in the Criminal Justice System EDWARD C. SENAY, M.D.* The American Medical Association's initiative to improve health care of inmates of American jails and prisons I includes
More informationTrends in treated problem cannabis use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to 2002
Drug Misuse Resear ch Divisio n Contents - Summary - Glossary of terms - Introduction - Methods - Analysis Trends in treated problem cannabis use in the seven health board areas outside the Eastern Regional
More informationTeen drug use continues down in 2006, particularly among older teens; but use of prescription-type drugs remains high
December 21, 2006 Contacts: Joe Serwach, (734) 647-1844 or jserwach@umich.edu Patti Meyer, (734) 647-1083 or mtfinfo@isr.umich.edu Study Web site: www.monitoringthefuture.org EMBARGOED FOR RELEASE AT 10
More informationNIDA-Modified ASSIST Prescreen V1.0 1
NIDA-Modified ASSIST Prescreen V1.0 1 F Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to
More informationSUBSTANCE ABUSE IN THE ELDERLY. The Invisible Epidemic
SUBSTANCE ABUSE IN THE ELDERLY The Invisible Epidemic IS IT POSSIBLE TO TEACH AN OLD DOG NEW TRICKS? GUIDELINES All forms of addiction know no age limit. Don t blame all problems on aging. Few realize
More informationOverall teen drug use continues gradual decline; but use of inhalants rises
December 21, 2004 Contact: Joe Serwach, (734) 647-1844 or jserwach@umich.edu or Patti Meyer, (734) 647-1083 or pmeyer@umich.edu Study Web site: www.monitoringthefuture.org EMBARGOED FOR RELEASE AFTER 11:30
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationAsk the Experts: The Intersection of Tobacco and Opioids
Ask the Experts: The Intersection of Tobacco and Opioids Association of State and Territorial Health Officials April 2, 2018 Participant Conference Line: 1-866-519-2796 Passcode: 816435# Vision State and
More informationEMBARGOED FOR RELEASE UNTIL 12:01 A.M. ET FRIDAY, SEPT. 8, 2017
Sept. 6, 2017 Contact: Morgan Sherburne, (734) 647-1844 morganls@umich.edu EMBARGOED FOR RELEASE UNTIL 12:01 A.M. ET FRIDAY, SEPT. 8, 2017 National study shows marijuana use among U.S. college students
More informationNIDA-Modified ASSIST - Prescreen V1.0*
NIDA-Modified ASSIST Assessment Instrument [1] NIDA-Modified ASSIST - Prescreen V1.0* *This screening tool was adapted from the WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Version
More informationUMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING
UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING Course Description Goals and Learning Objectives 55 Lake Ave North, Worcester, MA 01655 www.umassmed.edu/tobacco 1 Table of Contents Determinants of Nicotine
More informationDrug Use Around the World
Special Agents U.S. DRUG ENFORCEMENT AGENCY STAFFING AND BUDGETS 1975 2000 10000 5000 Total Employees 8000 6000 4000 3000 2000 4000 1975 1980 1985 1990 1995 2000 1000 1975 1980 1985 1990 1995 2000 Support
More informationCase Study Activity: Management of Attention-Deficit/Hyperactivity Disorder Answers to Interactive Questions and Resources
Case Study Activity: Management of Attention-Deficit/Hyperactivity Disorder Answers to Interactive Questions and Resources Case 3. Risk of Abuse of ADHD Medications Provider: American Pharmacists Association
More informationNeurobiology of Drug Abuse and Addiction PSYC 450
Neurobiology of Drug Abuse and Addiction PSYC 450 Healthy Control Drug Abuser Illicit drug use, lifetime and past year, in Canada 50 Canabis only Any drug Any of 5 drugs (without canabis) (CADUMS 2012)
More informationThe Impaired Professional. Peter Cohen, D.O.
The Impaired Professional Peter Cohen, D.O. Definition The American Medical Association (AMA) defines impairment as the inability to practice medicine with reasonable skill and safety to patients by reason
More informationSUBSTANCE ABUSE A Quick Reference Handout by Lindsey Long
Substance Abuse 1 SUBSTANCE ABUSE A Quick Reference Handout by Lindsey Long Diagnostic Criteria (APA, 2004) Within a 12 month period, a pattern of substance use leading to significant impairment or distress
More informationMarijuana use continues to rise among U.S. college students; use of narcotic drugs declines
Sept. 6, 2016 Contact: Jared Wadley, (734) 936 7819, jwadley@umich.edu Janice Lee, (734) 647 1083, janiice@umich.edu EMBARGOED FOR RELEASE UNTIL 12:01 A.M. ET THURSDAY, SEPT. 8, 2016 Note: Tables and figures
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification
More informationRemoving the Stigma from Substance Use Disorder. Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health
Removing the Stigma from Substance Use Disorder Joan Duwve, MD, MPH Associate Dean for Practice Richard M. Fairbanks School of Public Health Learning Objectives Recognize the impact of Stigma on getting
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationEMBARGOED FOR RELEASE AFTER 11:00 A.M. EST, FRIDAY, DEC. 19, 2003
The Drug study Page University 1 of Michigan News and Information Services 412 Maynard Ann Arbor, Michigan 48109-1399 December 19, 2003 Contact: Patti Meyer Phone: (734) 647-1083 E-mail: pmeyer@umich.edu
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationSubstance Use Disorders
Substance Use Disorders Substance Use Disorder This is a 15 minute webinar session for CNC physicians and staff CNC holds webinars monthly to address topics related to risk adjustment documentation and
More informationSAMPLE INITIAL EVALUATION TEMPLATE
I. Demographic Information Date: SAMPLE INITIAL EVALUATION TEMPLATE Name: Address: Phone (Home/Cell): Phone (Work): Date of Birth: Guardianship (for children and adults when applicable): Marital Status:
More informationMental Disorders Among OEF/OIF Veterans Using VA Health Care: Facts and Figures
Mental Disorders Among OEF/OIF Veterans Using VA Health Care: Facts and Figures Erin Bagalman Analyst in Health Policy January 11, 2013 CRS Report for Congress Prepared for Members and Committees of Congress
More informationW. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA
W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA Less severe mental disorder/more severe substance abuse disorder
More informationNational Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says
National Institute on Drug Abuse (NIDA) Understanding Drug Abuse and Addiction: What Science Says Last Updated February 2016 https://www.drugabuse.gov 1 Table of Contents Understanding Drug Abuse and Addiction:
More informationSUBSTANCE ABUSE UNIT UNIT PACKET NAME: PERIOD: SCORE:
SUBSTANCE ABUSE UNIT UNIT PACKET NAME: PERIOD: SCORE: _ \ SUBSTANCE ABUSE OVERVIEW IN-CLASS PROJECT DIRECTIONS: You will be working with your classmates to gather information about Substance Abuse. During
More informationMHS PSYCHOPATHOLOGY IN COUNSELING
MHS 6070 - PSYCHOPATHOLOGY IN COUNSELING This syllabus is a representative sample for this course. Specific information such as texts, assignments, and schedule may vary by semester. Catalog Description
More informationFACT SHEET. Women in Treatment
FACT SHEET Women in Treatment February 2011 The data in this fact sheet are based on clients in publicly funded and/or monitored alcohol and other drug treatment services in California during State Fiscal
More informationTRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS
Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationModule 6: Substance Use
Module 6: Substance Use Part 1: Overview of Substance Abuse I am Martha Romney and I am presenting on substance abuse. This module focuses on the healthy people 2020 objective to reduce substance abuse
More informationAnalyzing Indicators
Analyzing Indicators There are many ways to analyze indicators. The way(s) you analyze a given set of indicators will be based on your needs and how you intend to use the information. Sometimes you only
More informationEvidence table for systematic reviews
Evidence table for systematic reviews Topic: CB use and dependence Reviewer: CMF Abbreviations: y- years Reference Research Parameters Population Outcomes Funding Additional comments Bibliographic reference
More informationCommon Drug: The Realities and Misconceptions. Common Drug Users: The Realities and Misconceptions
Common Drug: The Realities and Misconceptions Common Drug Users: The Realities and Misconceptions Nick Alvarez Dr. McGee Drugs and Behavior April 14, 2016 Cocaine Cocaine appeals to individuals with obligations
More informationWelcome to: DRUG IMPAIRMENT TRAINING for EDUCATION PROFESSIONALS (DITEP) Day One
Welcome to: DRUG IMPAIRMENT TRAINING for EDUCATION PROFESSIONALS (DITEP) Day One DITEP Main Menu - Day I Session I: Introduction and Overview Session II: Drugs and Society Session III: Overview of Alcohol
More informationWashington State s Overdose Epidemic
Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research
More informationCigarettes and Other Nicotine Products
Cigarettes and Other Nicotine Products Nicotine is one of the most heavily used addictive drugs in the United States. In 2002, 30 percent of the U.S. population 12 and older 71.5 million people used tobacco
More informationIII. FREQUENTLY ASKED QUESTIONS
III. FREQUENTLY ASKED QUESTIONS 1. Why do adolescents take drugs? Adolescents experiment with drugs or continue taking them for several reasons, including: To fit in: Many teens use drugs because others
More informationPolysubstance Use & Medication-Assisted Treatment
Polysubstance Use & Medication-Assisted Treatment DSM-V eliminated polysubstance disorder, instead specifying each drug of abuse and dependence. Substance-use disorder is a combination of the two DSM-IV
More informationNational Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative
National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative The SCE Narrative is written by the Sentinel Community Epidemiologist (SCE) and provides
More informationEVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO
EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization
More informationUnit 1. Behavioral Health Course. ICD-10-CM Specialized Coding Training. For Local Health Departments and Rural Health
ICD-10-CM Specialized Coding Training http://publichealth.nc.gov/lhd/icd10/training.htm Behavioral Health Course For Local Health Departments and Rural Health Unit 1 1 Behavioral Health Training Objectives
More informationEvidence-Based Practice: Psychosocial Interventions
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio Talk Outline What is an evidence-based practice?
More informationMASS COMMUNICATIONS The traditional realm of mass communications includes television,
Appendix C: Perspectives on Defining Substance c Abuse F our broad arenas that encounter substance abuse-related issues include, mass communications, criminal justice, medicine, and public health. These
More informationNational Poison Data System: Louisiana Report Card
National Poison Data System: Louisiana 2012-2016 Report Card BACKGROUND This report details trends in Louisiana youth and young adults (ages 12-25) poison control rates captured by the National Poison
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification
More informationThere are no course prerequisites for this course other than being an RBA (Regents Bachelor of Arts) student.
RBIO3 BIO301 Drugs, Brain, and Behavior Master Course Syllabus Course Overview (QM Standards 1.2) Course description: Drugs, Brain and Behavior is an eight-week online, three credit hour course. The class
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) What has changed? Effective January 16, 2018, Coordinated Care will change the requirement for form HCA 13-333 Medication
More informationSubstance Use and youth: Current Trends, Engagement Techniques, and the benefits of Wraparound supports. Crystal Wytenus, MA, LPC, LCADC, NCC, ACS
Substance Use and youth: Current Trends, Engagement Techniques, and the benefits of Wraparound supports Crystal Wytenus, MA, LPC, LCADC, NCC, ACS Prescription pills Benzodiazepine s Marijuana Concentrates
More informationClinical Evaluation: Assessment Goals
Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment
More informationCHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE
CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE PRESENTED AND APPROVED: DECEMBER 7, 2012 EFFECTIVE: FALL 2013-14 Prefix & Number CHD 110 Purpose of this submission: Change course title to reflect current
More informationSUBSTANCE USE DISORDER IN ADOLESCENT POPULATION
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences SUBSTANCE USE DISORDER IN ADOLESCENT POPULATION ANNABELLE SIMPSON, MD UNIVERSITY OF WASHINGTON GENERAL DISCLOSURES
More informationMany drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.
1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationThe Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) دکتر راد گودرزی
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) 1 Expanded to include Gambling Disorder Cannabis Withdrawal and Caffeine Withdrawal are new disorders Caffeine Withdrawal
More informationTreatment Issues: The Opiate Crisis Among Us
Treatment Issues: The Opiate Crisis Among Us Presenter: Jessica Cirillo, BS, MA, ACRPS Clinical Supervisor & Relapse Prevention Specialist with Mirmont Treatment Center Facts About Addiction Addiction
More informationDrugs and Society. Glen R. Hanson. Peter J. Venturelli. Annette E. Fleckenstein
Drugs and Society Glen R. Hanson Department of Pharmacology and Toxicology* University of Utah Salt Lake City, Utah Director of the Division of Neuroscience and Behavioral Research National Institute on
More informationBASIC SKILLS FOR WORKING WITH SMOKERS
BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table
More information54 W Broadway Street, Suite 2 Shelbyville, Indiana January/February 2018
54 W Broadway Street, Suite 2 Shelbyville, Indiana 46176 317-398-3135 www.shelbycountydrugfree.com January/February 2018 Protecting Children from Prescription Stimulant Abuse Stimulant medications including
More informationSection 3 Alcohol, Tobacco and Other Drug Use Measurement
Section 3 Alcohol, Tobacco and Other Drug Use Measurement Drug use is measured by a set of 23 survey questions on the Communities That Care Youth Survey. The questions are similar to those used in the
More informationRole of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx
Role of PMPs in Preventing Substance Abuse National Conference of State Legislatures December 6, 2006 San Antonio, Tx Nick Reuter Division of Pharmacologic Therapy Substance Abuse and Mental Health Services
More informationClinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Executive Summary
More informationBehavioral Health Barometer. Oregon, 2015
Behavioral Health Barometer Oregon, 2015 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No. 283
More informationMental disorders are easily described. not easily defined. Castillo (1996)
History of the DSM Cornelia Pinnell, Ph.D. Argosy University/Phoenix Lecture Outline Why classification? A rationale. Classification of mental disorders a historical account of classification systems Census
More informationDOWNLOAD PDF PREVENTING DRUG USE AMONG YOUTH THROUGH COMMUNITY OUTREACH
Chapter 1 : Preventing Drug Misuse and Addiction: The Best Strategy National Institute on Drug Abuse (N Congress directed the military to establish pilot community outreach programs to reduce the demand
More informationName: Gender: male female Age: Date of birth: / / Preferred phone: cell home work other. Alternate phone: cell home work other.
Casey Alexander Paleos, MD NEW CLIENT INTAKE FORM 775 Park Avenue, Suite 200-2 Huntington, NY 11743 tel 631-629-5887 Date: / / BASIC INFORMATION Name: Gender: male female Age: Date of birth: / / Preferred
More informationOpioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
More informationCO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS
INTEGRATING COMBINED THERAPIES (ICT) FOR CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 2009 MARRCH CONFERENCE 22 October 2009 CO-OCCURRING SUBSTANCE USE AND PSYCHIATRIC DISORDERS 1. Common in the
More informationBehavioral Health Barometer. North Dakota, 2013
Behavioral Health Barometer North Dakota, 2013 Acknowledgments This report was prepared for the Substance Abuse and Mental Health Services Administration (SAMHSA) by RTI International under contract No.
More informationCICAD. Report on Drug Use in the Americas Executive Summary INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION CICAD SIXTY-FOURTH REGULAR SESSION November 19-21, 2018 Washington D.C., USA OEA/Ser.L/XIV.2.64 CICAD/doc. 2435/18 November 20 2018 Original: English Report
More informationMore Than Just a Higher Grade
April 2008 Article 4 April 2008 More Than Just a Higher Grade Courtney Peterson Iowa State University Follow this and additional works at: http://lib.dr.iastate.edu/ethos Recommended Citation Peterson,
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationThe Opioid Crisis among the Privately Insured
The Opioid Crisis among the Privately Insured The Opioid Abuse Epidemic as Documented in Private Claims Data A FAIR Health White Paper, July 2016 Copyright 2016, FAIR Health, Inc. Summary The United States
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Methadone and buprenorphine for the management of opioid dependence
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Appraisal Methadone and buprenorphine for the management of opioid dependence Comments received from Consultees and Commentators on the draft scope
More informationClinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)
Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT) For Apple Health clients served Fee-for-Service and through contracted Medicaid Managed Care Organizations Updated January
More informationMagnitude. SELECT A TOPIC...
Page 1 of 6 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Magnitude Drug Abuse is Costly Drug abuse is a major public health problem
More informationCourse Catalog. Early Intervention, Treatment, and Management of Substance Use Disorders
Course Catalog To take a course, visit our website at https://www.mindfulceus.com - You can link directly to a course by visiting https://www.mindfulceus.com/course/id where ID is the ID number listed
More informationAlcohol xanax cross tolerance
An alcoholic will also have a cross-tolerance for benzodiazepine, because both drugs affect the brain in similar ways. This is why alcoholics who have never abused benzodiazepine are often prescribed the
More informationUniversity of Pittsburgh
Learning Objectives Participants will be able to: Associate the history of prescription drug use in America with the current trend of prescription drug abuse; Differentiate between the three most commonly
More informationRelationship of Gender to Licit and Illicit Drug Use among Adolescents. Katherine Haas
Relationship of Gender to Licit and Illicit Drug Use among Adolescents Katherine Haas ABSTRACT This study examines the relationship of gender to licit and illicit drug use among adolescents. The licit
More informationSubstance Use and Addictive Disorders
Key Dates TU Feb 14 Unit 8 147-end and Unit 9; MW Ch 8 Jeffrey and Ch 10 Diana TH Feb 16 Unit 10; MW Ch 11 Theodore B TU Feb 21 Monday class schedule TH Feb 23 Begin Dimensions-Cognition, Units IIC and
More informationAlcohol Use in the Elderly
Substance Use/Abuse in the Geriatric Population Alan L. Schneider, MD DFAPA DABAM Medical Director, Western Region Aetna Behavioral Health Associate Professor of Psychiatry, UCLA School of Medicine Alcohol
More informationNeonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)
Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit
More informationOPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know
OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know WHAT S NEW UPDATE CUMBERLAND, MD Renata J. Henry, M.Ed. Director, Central East ATTC March 16, 2016 Behavioral Health is Essential to Health
More informationJuly 6, Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration New Hampshire Avenue Silver Spring, MD 20993
Scott Gottlieb, MD Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 RE: Draft Revisions to the Food and Drug Administration Blueprint for Prescriber Education
More informationThe Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth
The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)
More informationBrief History of Methadone Maintenance Treatment
METHADONE Brief History of Methadone Maintenance Treatment Methadone maintenance treatment was on the cusp of the social revolution in the sixties. Doctors and public health workers had concluded what
More information